Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
14.55
-0.40 (-2.68%)
Mar 19, 2026, 3:04 PM CST
SHE:300401 Revenue
Zhejiang Garden Biopharmaceutical had revenue of 300.34M CNY in the quarter ending September 30, 2025, a decrease of -10.99%. This brings the company's revenue in the last twelve months to 1.24B, up 9.43% year-over-year. In the year 2024, Zhejiang Garden Biopharmaceutical had annual revenue of 1.24B with 13.58% growth.
Revenue (ttm)
1.24B
Revenue Growth
+9.43%
P/S Ratio
6.37
Revenue / Employee
1.22M
Employees
1,021
Market Cap
7.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.24B | 148.63M | 13.58% |
| Dec 31, 2023 | 1.09B | -322.86M | -22.78% |
| Jan 1, 2023 | 1.42B | 300.41M | 26.89% |
| Jan 1, 2022 | 1.12B | 457.66M | 69.40% |
| Dec 31, 2020 | 659.44M | -58.95M | -8.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 6.85B |
| China Animal Husbandry Industry | 6.28B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Shandong Wit Dyne Health | 2.36B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| Jiuzhitang | 1.94B |